Managing Principal Joshua White Joins ThoughtLeaders4 UK Class Actions Forum Panel on Data Privacy and Cybersecurity Risks and Liability
Event: ThoughtLeaders4 Disputes UK Class Actions Forum – 6th Annual Dates: 14–15 October 2026 Host: ThoughtLeaders4 Disputes Location: London, UK
Analysis Group Managing Principal Joshua White will join a panel on data privacy and cybersecurity risks and liability at the ThoughtLeaders4 (TL4) UK Class Actions Forum. The event brings together experts with first-hand experience on both claimant and defendant sides of class action litigation in the UK. The panel on data privacy and cybersecurity risks and liability will explore the evolving landscape of data breach and privacy class actions, competing approaches to damages and loss-of-control cases, and the role of expert evidence and technical investigations.
The panel will also feature Emily Cox (Pinsent Masons), John Yanchunis (Morgan & Morgan), Chaya Hanoomanjee (Austen Hays), and Justin Collins (Epiq).
Associated People
Joshua White
Managing PrincipalMr White is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger-related questions, primarily in matters involving the health care, financial services and technology industries. He has supported clients in various jurisdictions and industries in follow-on competition damages litigation, assessing overcharge, upstream and downstream pass-on and volume effects. He has served as a testifying expert in the UK Upper Tribunal (Lands Chamber), the UK Competition Appeal Tribunal and the Amsterdam District Court on competition cases.
Mr White has supported high-profile companies with complex merger reviews across multiple jurisdictions, including in the Veolia/Suez, LVMH/Tiffany, Sika/MBCC and Eutelsat/OneWeb mergers. He has also provided evidence to the UK’s Competition and Markets Authority (CMA) and the European Commission (EC), including on behalf of clients involved in cartel investigations, abuse of dominance investigations and mergers. Mr White has also provided support to European financial and competition regulators in coordinated conduct investigations.
Mr White has extensive experience addressing competition and intellectual property (IP) issues in matters related to cutting-edge pharmaceutical products and FRAND licensing questions. As part of this work, he has supported a number of scientific and technical experts in front of courts and regulatory bodies. He also regularly supports pharmaceutical clients on competition issues around market access, pricing, denigration and competition from generic manufacturers.
Mr White has worked in a number of jurisdictions, including the UK, the European Union, Switzerland, Australia, New Zealand, South Africa, Canada, Japan, Korea, the Netherlands, Belgium and the US. His writing has been published in an array of journals, including the Journal of European Competition Law & Practice, the Competition Law Journal and the Journal of Antitrust Enforcement, and he regularly speaks at international competition law and policy conferences.